1. IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY. (12th June 2019) Authors: Greil, R.; Tedeschi, A.; Moreno, C.; Anz, B.; Larratt, L.; Simkovic, M.; Gill, D.; Gribben, J.G.; Flinn, I.W.; Wang, Z.; Cheung, L.W.; Nguyen, A.N.; Zhou, C.; Styles, L.; Demirkan, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PB1889: A CASE OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA INDUCED IMMUNE THROMBOCYTOPENIC PURPURA SUCCESSFULLY TREATED WITH VENETOCLAX. (23rd June 2022) Authors: Yavuz, B.; Karatas, A. F.; Erdogan Yucel, E.; Seker, O.; Guven, S.; Kakci, M.; Ozsan, G. H.; Alacacioglu, I.; Demirkan, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2181: DOES SARCOPENIA INFLUENCE THE SUCCESS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION?. (23rd June 2022) Authors: Erdogan Yucel, E.; Alacacioglu, I.; Karatas, A. F.; Yavuz, B.; Kakci, M.; Seker, O.; Ozsan, G. H.; Demirkan, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB2007: FACTORS ASSOCIATED WITH EARLY RELAPSE IN MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Karatas, A.; Yavuz, B.; Erdogan Yucel, E.; Kakci, M.; Ozsan, G. H.; Alacacioglu, I.; Demirkan, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 247 HYPOALBUMINEMIA IS A SURROGATE BIOMARKER OF POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME EVEN WHEN ADJUSTED WITH COMORBIDITIES. Issue 1 (April 2015) Authors: Sevindik, O.; Guc, Z.; Kahraman, S.; Medeni, S.; Katgi, A.; Acar, C.; Alacacioglu, I.; Piskin, O.; Ozsan, H.; Demirkan, F.; Undar, B.; Ozcan, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL. (June 2017) Authors: Cramer, P.; Demirkan, F.; Fraser, G.; Pristupa, A.; Bartlett, N.; Dilhuydy, M.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; Poggesi, I.; Lavezzi, S.M.; De Nicolao, G.; de Jong, J.; Neyens, M.; Salman, M.; Howes, A.; Mahler, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗